Primary antiphospholipid antibody syndrome - One further aspect of thrombophilia in overweight and obese patients with venous thromboembolism

Obesity

Volumn 21, Issue 9, 2013, Pages

  Gary, Thomas ^a   Belaj, Klara ^a   Bruckenberger, Rosa ^a   Hackl, Gerald ^a   Hafner, Franz ^a   Froehlich, Harald ^a   Zebisch, Armin ^a   Pilger, Ernst ^a   Brodmann, Marianne ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; FIBRINOGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT;

ADULT; ARTICLE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OBESITY; PRIMARY PHOSPHOLIPID ANTIBODY SYNDROME; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BODY MASS INDEX; BODY WEIGHT; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 84884904160     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20188     Document Type: Article

References (14)

1. Borch KH, Nyegaard C, Hansen JB, et al. Joint effects of obesity and body height on the risk of venous thromboembolism: the Tromso Study. Arterioscler Thromb Vasc Biol 2011; 31: 1439-1444.
2. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
3. Reverter JC, Tassies D, Font J, et al. Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein s. Arterioscler Thromb Vasc Biol 1996; 16: 1319-1326.
4. Wu XX, Pierangeli SS, Rand JH,. Resistance to annexin A5 binding and anticoagulant activity in plasmas from patients with the antiphospholipid syndrome but not with syphilis. J Thromb Haemost 2006; 4: 271-273.
5. Medina G, Casaos D, Jara LJ, et al. Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome. Ann Rheum Dis 2003; 62: 607-610.
6. Medina G, Gutierrez-Moreno AL, Vera-Lastra O, Saavedra MA, Jara LJ,. Prevalence of metabolic syndrome in primary antiphospholipid syndrome patients. Autoimmun Rev 2011; 10: 214-217.
7. Caldas CA, da Mota LM, de Carvalho JF,. Obesity in primary antiphospholipid syndrome is associated with worse outcome. Joint Bone Spine 2011; 78: 324-325.
8. Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009; 7: 1737-1740.
9. Willis R, Harris EN, Pierangeli SS,. Pathogenesis of the antiphospholipid syndrome. Semin Thromb Hemost, in press.
10. Paupitz JA, Freire de Carvalho J, Caparbo VF, Klack K, Pereira RM,. Primary antiphospholipid syndrome in premenopausal women: low vitamin D, high fat mass and maintained bone mineral mass. Lupus 2010; 19: 1302-1306.
11. Sailer T, Vormittag R, Pabinger I, et al. Inflammation in patients with lupus anticoagulant and implications for thrombosis. J Rheumatol 2005; 32: 462-468.
12. Bobba R, Landolt-Marticorena C, Fortin PR,. Thrombosis and inflammation: a question in need of an answer. J Rheumatol 2005; 32: 397-399.
13. Calder PC, Ahluwalia N, Brouns F, et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr 2011; 106 (Suppl 3): S5-S78.
14. Heggen E, Klemsdal TO, Haugen F, Holme I, Tonstad S,. Effect of a low-fat versus a low-glycemic-load diet on inflammatory biomarker and adipokine concentrations. Metab Syndr Relat Disord, in press.